Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 08:30 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program

"The foundation is clearly there and as a result, we believe we are undervalued significantly,” said Mr. James Nathanielsz, Propanc’s CEO
May 20, 2026 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade

These findings reinforce the importance of continuing to deepen our understanding of the underlying biology that drives both growth and resistance.